tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Beta Bionics price target raised to $17 from $15 at Baird

Baird raised the firm’s price target on Beta Bionics (BBNX) to $17 from $15 and keeps a Neutral rating on the shares. The firm updated its model following solid Q2 results but being left with remaining higher uncertainties.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1